NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 283 filers reported holding NATERA INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,979,797 | +12.8% | 248,131 | +24.0% | 2.08% | +60.9% |
| Q2 2023 | $9,736,574 | -25.8% | 200,094 | -15.4% | 1.29% | -2.9% |
| Q1 2023 | $13,126,594 | +98.0% | 236,430 | +43.3% | 1.33% | +288.6% |
| Q4 2022 | $6,628,050 | +210.9% | 165,000 | +174.3% | 0.34% | +175.8% |
| Q2 2022 | $2,132,000 | -90.3% | 60,159 | -74.4% | 0.12% | -84.4% |
| Q4 2021 | $21,965,000 | -18.1% | 235,199 | -2.3% | 0.80% | -2.6% |
| Q3 2021 | $26,823,000 | +9.0% | 240,693 | +11.0% | 0.82% | +6.5% |
| Q2 2021 | $24,615,000 | -2.1% | 216,816 | -12.4% | 0.77% | +6.8% |
| Q1 2021 | $25,146,000 | +24.8% | 247,644 | +22.3% | 0.72% | -2.2% |
| Q4 2020 | $20,153,000 | +46.8% | 202,500 | +6.6% | 0.73% | +3.7% |
| Q3 2020 | $13,726,000 | +212.7% | 190,000 | +45.8% | 0.71% | +83.2% |
| Q4 2019 | $4,390,000 | +346.1% | 130,300 | +334.3% | 0.39% | +129.8% |
| Q3 2019 | $984,000 | -42.0% | 30,000 | -57.7% | 0.17% | -52.9% |
| Q3 2018 | $1,697,000 | – | 70,871 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,100,560 | $314,831,000 | 18.93% |
| Blue Water Life Science Advisors, LP | 328,836 | $33,390,000 | 16.31% |
| Foresite Capital Management III, LLC | 127,305 | $12,927,000 | 11.35% |
| HWG Holdings LP | 148,794 | $15,109,000 | 7.53% |
| Eagle Health Investments LP | 168,394 | $17,099,000 | 6.71% |
| Lagoda Investment Management, L.P. | 103,325 | $10,492,000 | 5.24% |
| Ally Bridge Group (NY) LLC | 218,000 | $22,136,000 | 4.24% |
| PERKINS CAPITAL MANAGEMENT INC | 63,950 | $6,493,000 | 3.76% |
| BRIDGER MANAGEMENT, LLC | 388,620 | $39,460,000 | 3.68% |
| Hudson Executive Capital LP | 527,086 | $53,520,000 | 3.32% |